Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Gynecol Oncol. 2015 Dec 31;140(3):394–399. doi: 10.1016/j.ygyno.2015.12.028

Table 3.

Adjuvant therapy

SLN cohort
N=642
LND cohort
N=493
P
Adjuvant therapy, N (%) <0.001
    No adjuvant therapy 466 (72.6) 432 (87.6)
    IVRT only 113 (17.6) 30 (6.1)
    EBRT ± IVRT 6 (0.9) 3 (0.6)
    Chemotherapy ± IVRT 30 (4.7) 13 (2.6)
    Chemotherapy and EBRT ± IVRT 17 (2.6) 7 (1.4)
    Hormones 8 (1.2) -
    Unknown 2 (0.3) 8 (1.6)

SLN, sentinel lymph node; LND, lymph node dissection; IVRT, intravaginal brachytherapy; EBRT, external beam radiation therapy